Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity.

Kang E, Yun CO.

BMB Rep. 2010 Dec;43(12):781-8. doi: 10.5483/BMBRep.2010.43.12.781. Review.

2.

Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.

Gao JQ, Eto Y, Yoshioka Y, Sekiguchi F, Kurachi S, Morishige T, Yao X, Watanabe H, Asavatanabodee R, Sakurai F, Mizuguchi H, Okada Y, Mukai Y, Tsutsumi Y, Mayumi T, Okada N, Nakagawa S.

J Control Release. 2007 Sep 11;122(1):102-10. Epub 2007 Jun 21.

PMID:
17628160
3.

Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration.

Yao X, Yoshioka Y, Morishige T, Eto Y, Narimatsu S, Mizuguchi H, Mukai Y, Okada N, Nakagawa S.

Biol Pharm Bull. 2010;33(6):1073-6.

4.

[Development of pegylated adenovirus vector for cancer gene therapy].

Eto Y, Yoshioka Y, Asavatanabodee R, Mizuguchi H, Mukai Y, Okada N, Nakagawa S.

Yakugaku Zasshi. 2008 Dec;128(12):1733-42. Review. Japanese.

5.
6.

Development of PEGylated adenovirus vector with targeting ligand.

Eto Y, Yoshioka Y, Mukai Y, Okada N, Nakagawa S.

Int J Pharm. 2008 Apr 16;354(1-2):3-8. Epub 2007 Aug 24. Review.

PMID:
17904316
7.

Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.

Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C.

J Gene Med. 2006 Jun;8(6):679-89.

PMID:
16570242
8.

Current targeting strategies for adenovirus vectors in cancer gene therapy.

Yao XL, Nakagawa S, Gao JQ.

Curr Cancer Drug Targets. 2011 Sep;11(7):810-25. Review.

PMID:
21762081
9.

Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy.

Park Y, Kang E, Kwon OJ, Hwang T, Park H, Lee JM, Kim JH, Yun CO.

J Control Release. 2010 Nov 20;148(1):75-82. doi: 10.1016/j.jconrel.2010.06.027. Epub 2010 Jul 15.

PMID:
20637814
10.

Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.

Seiler MP, Cerullo V, Lee B.

Curr Gene Ther. 2007 Oct;7(5):297-305. Review.

PMID:
17979676
11.

Utilizing adenovirus vectors for gene delivery in cancer.

Kasala D, Choi JW, Kim SW, Yun CO.

Expert Opin Drug Deliv. 2014 Mar;11(3):379-92. doi: 10.1517/17425247.2014.874414. Epub 2014 Jan 7. Review.

PMID:
24392755
12.

Advances towards targetable adenovirus vectors for gene therapy.

Einfeld DA, Roelvink PW.

Curr Opin Mol Ther. 2002 Oct;4(5):444-51. Review.

PMID:
12435045
13.

Use of protamine to augment adenovirus-mediated cancer gene therapy.

Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S.

Gene Ther. 1999 Sep;6(9):1600-10.

14.

Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.

Benihoud K, Esselin S, Descamps D, Jullienne B, Salone B, Bobé P, Bonardelle D, Connault E, Opolon P, Saggio I, Perricaudet M.

Gene Ther. 2007 Mar;14(6):533-44. Epub 2006 Nov 16. Erratum in: Gene Ther. 2007 Mar;14(6):551.

PMID:
17109009
15.

Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.

Xu F, Li S, Li XL, Guo Y, Zou BY, Xu R, Liao H, Zhao HY, Zhang Y, Guan ZZ, Zhang L.

Cancer Gene Ther. 2009 Sep;16(9):723-30. doi: 10.1038/cgt.2009.19. Epub 2009 Apr 10.

PMID:
19363470
17.

Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.

Haegel-Kronenberger H, Haanstra K, Ziller-Remy C, Ortiz Buijsse AP, Vermeiren J, Stoeckel F, Van Gool SW, Ceuppens JL, Mehtali M, De Boer M, Jonker M, Boon L.

Gene Ther. 2004 Feb;11(3):241-52.

PMID:
14737083
18.

Repeated administration of adenovector in the eye results in efficient gene delivery.

Hamilton MM, Brough DE, McVey D, Bruder JT, King CR, Wei LL.

Invest Ophthalmol Vis Sci. 2006 Jan;47(1):299-305.

PMID:
16384977
19.

Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery.

Li E, Brown SL, Von Seggern DJ, Brown GB, Nemerow GR.

Gene Ther. 2000 Sep;7(18):1593-9.

Supplemental Content

Support Center